In contrast, the level of CCN1 is elevated in the entire epidermis of the lesional skin of psoriasis patients and promotes the production of Interleukin-8 (IL-8), IL-1β and C–C Motif Chemokine Ligand 20, which drives psoriatic inflammation and skin barrier disruption9–11. The gene discussed is CCN1; the disease is psoriasis.